Expert Review of Gastroenterology & Hepatology

Article	Citations
Ripretinib for the treatment of adult patients with advanced gastrointestinal stromal tumors	45
Imaging in pediatric disorders of the gut-brain interactions: current best practice and future directions	37
Small bowel transplant – novel indications and recent progress	31
Multidetector computed tomography angiography in non-variceal upper gastrointestinal bleeding: when, why and how?	31
Managing pain in irritable bowel syndrome: current perspectives and best practice	29
Leucine-rich alpha-2 glycoprotein as a blood biomarker in inflammatory bowel disease: clinical implications and future perspectives	26
Early alpha-fetoprotein response predicts prognosis of immune checkpoint inhibitor and targeted therapy for hepatocellular carcinoma: a systematic review with meta-analysis	25
Addressing current limitations of colonoscopy for colorectal cancer screening	25
Terlipressin in the management of adults with hepatorenal syndrome-acute kidney injury (HRS-AKI)	25
Impact of yoga therapy in intestinal disorders	25
Elucidating the role of extracellular vesicles in liver injury induced by HIV	25
Extra-pancreatic malignancies in patients with intraductal papillary mucinous neoplasms	24
Gender-related differences in celiac disease presentation and follow-up in adult patients	24
A narrative review on the diagnosis and management of constipation in infants	23
Treatment optimization of subcutaneous infliximab in patients with inflammatory bowel disease	23
Familial intestinal polyposis and device assisted enteroscopy: where do we stand?	22
Irritable bowel syndrome – controversies in diagnosis and management	22
Targeting liver metabolism: a pathway to cure hepatitis B virus?	21
Recent advances in treating constipation in children	20
Therapeutic drug monitoring in inflammatory bowel disease: recent developments	20
High-dosage human albumin infusion may be superior for hypervolemic hyponatremia in cirrhosis with ascites	19
Lipid biomarkers in colorectal cancer, with particular emphasis on exosomes – current status and future inferences	19
Investigating the correlation between COVID-19 and the progression of chronic liver disease	18
ERCP-related adverse events: incidence, mechanisms, risk factors, prevention, and management	18
Bayesian analysis and the role of local palliative therapeutics for malignant biliary obstruction	18

Contemporary advances in the endoscopic management of cholangiocarcinoma: a review of accomplished milestones and prospective opportunities	18
The assessment of impaired liver function and prognosis in hepatocellular carcinoma	18
Characteristic endoscopic findings in Helicobacter pylori diagnosis in clinical practice	17
Impact of biologic therapies and small molecules on the risk of major adverse cardiovascular events in patients with inflammatory bowel diseases: systematic review and meta-analysis of randomized cont	17
Preoperative endoscopic ultrasound-guided biliary drainage for primary drainage in obstructive jaundice	17
An insight into Clostridioides difficile-associated diarrhea in Saudi children: diagnosis and treatment	17
Recent updates on treatment options for primary follicular lymphoma of the gastrointestinal tract	17
Misinterpretation and misapplication of biomarkers in inflammatory bowel disease: how do we avoid this?	16
The evolution of irritable bowel syndrome as a group of organic diseases: a narrative review	16
Small bowel imaging in inflammatory bowel disease: updates for 2023	15
Altered gut microbiota is associated with sleep disturbances in patients with minimal hepatic encephalopathy caused by hepatitis B-related liver cirrhosis	15
Vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis	15
Managing bile acid diarrhea: aspects of contention	14
Updates on intestinal failure management	14
Evaluating the role of endoscopic ultrasound in pancreatitis	14
Impact of the COVID-19 pandemic on hospitalizations with hepatocellular carcinoma in the United States	14
To STRIDE or not to STRIDE: a critique of “treat to target” in ulcerative colitis	14
IBD in women of reproductive age: where do novel therapies fit in?	14
Psychological distress in inflammatory bowel disease	13
Cost-effectiveness of tislelizumab plus chemotherapy vs chemotherapy as first-line treatment of PD-L1 positive advanced gastric or gastroesophageal junction adenocarcinoma from a Chinese perspective	13
Highlights of the drug-induced liver injury literature for 2021	13
The impact of a multidisciplinary team evaluation on the diagnosis and management of acute and chronic pancreatitis in a tertiary referral center	13
Primary biliary cholangitis (PBC): evolving approaches and expert perspectives	12
An update on improving long-term outcomes for patients with chronic pancreatitis post-surgery	12
Carcinoid syndrome mimicking irritable bowel syndrome: don’t fall into the trap	12
Artificial intelligence implementation in pancreaticobiliary endoscopy	12
Managing pediatric Crohn’s disease: recent insights	12
Gastroesophageal reflux disease in preterm infants: unmet needs	11
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma	11
Managing complications of chronic pancreatitis: a guide for the gastroenterologist	11
Diagnosing eosinophilic esophagitis in pediatric patients	11
Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis	11
Relationship between pathogenic microorganisms and the occurrence of esophageal carcinoma based on pathological type: a narrative review	11
Interrupting inflammatory bowel disease therapy: why, who, when and how to consider medication holidays	11
Relief from behind: enemas, the back door enforcement to help treating chronic constipation in adults	11
Updates in interaction of gastroesophageal reflux disease and extragastroesophageal digestive diseases	10
EUS-guided gastro-enteral anastomosis for the treatment of gastric outlet obstruction: is the end of the enteral stent?	10
Reply to letter to the Editor: Vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis	10
Towards a better diagnosis of gastro esophageal reflux disease	10
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art	10
An update on efficacy and safety comparison of biologics in treatment of inflammatory bowel disease targeting TNF-α, interleukins, leukocyte trafficking, Janus-kinase, and sphingosine-1-phosphate rece	10
The efficacy and safety of glucocorticoid for perioperative patients with hepatectomy: a systematic review and meta-analysis	10
Management of disease-related abdominal abscesses in Crohn’s disease	10
Paraneoplastic syndromes in hepatocellular carcinoma: a review	9
Post-endoscopic submucosal dissection electrocoagulation syndrome: a clinical overview	9
Development and validation of modified Liaoning score for predicting the prognosis of liver cirrhosis: a retrospective, international multicenter, observational study	9
Measuring gut microbiome as a colorectal cancer screening tool: potential and challenges	9
Modulating the microbiome in chronic liver diseases – current evidence on the role of fecal microbiota transplantation	9
Highlighting novel targets in immunotherapy for liver cancer	9
Clinical role of anti-PD-1 immunotherapies in esophageal cancer	8

Characterizing Crohn’s disease phenotypes through pan-enteric capsule endoscopy	8
Systematic mapping of worldwide research on intra-pancreatic fat deposition	8
Nosocomial spontaneous bacterial peritonitis is associated with high mortality – a systematic review and meta-analysis	8
Introducing the “Guideline Comparison” article type	8
Assessment of efficacy and prognostic factors by Gelfoam for DEB-TACE in unresectable large hepatocellular carcinoma with portal vein tumor thrombus: a multi-center retrospective study	8
The TL1A inhibitors in IBD: what’s in the pot?	8
Endoscopic follow-up in patients with first-degree relatives for gastric cancer: a real-world observational study	8
Cross-regulation between microRNAs and key proteins of signaling pathways in hepatocellular carcinoma	8
Exploring immunological perturbations between hepatocellular carcinoma risk, inflammation and obesity	8
Induction and maintenance of healing in erosive esophagitis in the United States	8
Clinical management of inflammatory bowel disease from preconception to postpartum	8
Acute severe ulcerative colitis: defining the precise moment for colectomy	8
Autoimmune gastritis: an organ-specific disease or a model of systemic autoimmunity? Parallels, divergences, and emerging insights	8
Extra-intestinal manifestations in inflammatory bowel disease: a comparative review of pediatric and adult-onset disease	8
PSC patient with jaundice – should we ERCP?	8
Radiation safety and dose management in fluoroscopy-guided gastrointestinal procedures: current evidence and future perspectives	8
Medical management of acute severe ulcerative colitis in the hospitalized patient	8
Safety and use of IBD therapies during pregnancy and lactation	8
Prioritization in inflammatory bowel disease therapy	7
Reviewing novel findings and advances in diagnoses and treatment of primary biliary cholangitis	7
Noninvasive electrical neuromodulation for gastrointestinal motility disorders	7
Adenoma detection rate in colonoscopy: how can it be improved?	7
The role of immunogenicity in optimizing biological therapies for inflammatory bowel disease	7
How widespread and convenient H. pylori susceptibility testing will result in pharmacological opportunities	7
Histamine-producing bacteria and their role in gastrointestinal disorders	7
Endoscopic ultrasound-guided pancreatic duct drainage: a comprehensive state of the art review	7
Nutritional aspects of inflammatory bowel disease	7
Proton beam therapy in the management of hepatocellular carcinoma	7
A contemporary review of care gaps in hepatocellular carcinoma surveillance	7
Short bowel syndrome-associated intestinal failure: diagnosis and prognosis	7
To STRIDE or not to STRIDE: a critique of “treat to target” in Crohn´s disease	7
Innovations in the diagnosis, treatment, and management of disorders of gut-brain interaction (DGBI)	7
Use of fiber-containing enteral formula in pediatric clinical practice: an expert opinion review	7
The position of anti-tumor necrosis factor agents for the treatment of adult patients with Crohn’s disease	7
Novel fibro-inflammatory biomarkers associated with disease activity in patients with Crohn’s disease	7
Mistakes in managing hepatocellular carcinoma and how to avoid them: a narrative review	7
2023 update on the clinical management of gastroparesis	7
A critical review of upadacitinib for the treatment of adults with moderately to severely active ulcerative colitis	7
Significance of nucleologenesis, ribogenesis, and nucleolar proteome in the pathogenesis and recurrence of hepatocellular carcinoma	7
The meaning of R1 resection after endoscopic removal of gastric, duodenal and rectal neuroendocrine tumors	7
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms	7
Analysis of the impact on efficacy of lubiprostone dose reduction to manage adverse events in the treatment of chronic constipation in Japan	7
Primary biliary cholangitis: primary autoimmune disease or primary secretory defect	7
Recent advances in the treatment of gastrointestinal motility disorders in children	6
Letter to the editor: vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis	6
Practical management of mild-to-moderate ulcerative colitis: an international expert consensus	6
Integrating behavioral interventions into a holistic approach to metabolic dysfunction-associated steatotic liver disease	6
Endoscopic ultrasonography guided gallbladder drainage: “how and when”	6
Low-grade hepatocellular carcinoma characteristics, a practical nomogram and risk stratification system: a SEER population-based study	6
Targeting MET amplification in Gastro-oesophageal (GO) malignancies and overcoming MET inhibitor resistance: challenges and opportunities	6
Influence of metabolic dysfunction-associated fatty liver disease on the prognosis of patients with HBV-related acute-on-chronic liver failure	6
What are the true benefits of robotic pancreaticoduodenectomy for patients with pancreatic cancer?	6
The eternal dichotomy between early biologic therapy and early surgery in Crohn’s disease: which should truly take precedence?	6
Screening for MASLD in patients with type 2 diabetes: is an early diagnosis a good diagnosis?	6
Comprehensive care of ulcerative colitis: new treatment strategies	6
Stratification of obesity phenotypes to optimize future therapy (SOPHIA)	6
Before the scope: precision medicine in medication management for endoscopic safety and quality	6
Strengths and limitations of risk stratification tools for patients with upper gastrointestinal bleeding: a narrative review	6
Advancements in the prevention and management of postoperative Crohn’s disease recurrence	6
Securing the diagnosis of HRS-AKI: implications for current therapies	6
Evaluating the molecular and genetic mechanisms underlying gut motility disorders	6
Transjugular intrahepatic portosystemic shunt with or without variceal embolization to prevent variceal rebleeding: an updated meta-analysis	6
Antireflux surgery – choosing the right candidate	5
Occult hepatitis B infection – unveiling clinical burden and new diagnostic strategies	5
Filgotinib for moderately to severely active ulcerative colitis	5
Impact of peptic ulcer bleeding on the in-hospital outcomes of cirrhotic patients with acute gastrointestinal bleeding: an international multicenter study	5
Is high resolution manometry pertinent in eosinophilic esophagitis assessment?	5
From liver to gut: the hidden gastrointestinal impact of pediatric metabolic dysfunction-associated steatotic liver disease	5
Irritable bowel syndrome in the elderly: epidemiology, diagnosis, treatment, and relationship with frailty	5
Screening for pancreatic cancer has the potential to save lives, but is it practical?	5
Dual energy computed tomography in Crohn’s disease: a targeted review	5
Sleeve gastrectomy with transit bipartition: a review of the literature	5
Statins decrease overall mortality and cancer related mortality but are underutilized in NAFLD: a longitudinal analysis of 12,538 individuals	5
Gastroparesis treatment options metoclopramide and prucalopride: analysis of the FDA Adverse Event Reporting System (FAERS) database	5
Spontaneous swallowing frequency in the evaluation of swallowing function	5
Clinical efficacy and safety of robot assisted surgery for choledochal cysts excisions: a systematic review and meta-analysis	5
Capsule endoscopy - a non-invasive modality to investigate the GI tract: out with the old and in with the new?	5
Advances in our understanding of the molecular heterogeneity of fatty liver disease: toward informed treatment decision making	5
Cold resection for colorectal polyps: where we are and where we are going?	5
Positioning of tofacitinib in treatment of ulcerative colitis: a global perspective	5

The emerging roles of intestinal organoid models in inflammatory bowel disease research	5
Etiologic factors for Barrett’s esophagus: toward countermeasures in Asia	5
Esophageal lymphocytosis: exploring the knowns and unknowns of this pattern of esophageal injury	5
How to predict abnormal acid reflux: recent developments	5
CEUS compared with CECT, MRI, and FDG-PET/CT for diagnosing CRC liver metastases: a diagnostic test accuracy systematic review and meta-analysis	5
Novel therapeutics to treat chronic pancreatitis: targeting pancreatic stellate cells and macrophages	4
Mistakes in utilising histopathology for the management of liver disease	4
The non-surgical therapy of uncomplicated gallbladder stones: is there a niche?	4
Revolutionizing liver fibrosis research: the promise of 3D organoid models in understanding and treating chronic liver disease	4
The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry	4
Novel approaches in the medical management of compensated cirrhosis	4
A critical review of ozanimod for the treatment of adults with moderately to severely active ulcerative colitis	4
Hepatobiliary disease after bone marrow transplant	4
Advances in target drugs and immunotherapy for biliary tract cancer	4
Validated approaches at mayo clinic for measuring gastric and colonic transit of solids and gastric accommodation	4
Endoscopic ultrasound guided liver biopsy and portal pressure gradient: when, why and how? Can it become the standard of care in endo-hepatology?	4
Identifying and managing rare subtypes of gastrointestinal stromal tumors	4
Antireflux surgeries and hiatal repair: keys to success	4
Recommendations for the management of gastrointestinal comorbidities with or without trofinetide use in Rett syndrome	4
Eosinophilic esophagitis in the era of biologics	4
Ulcerative colitis, frailty, and beyond	4
Antibiotics in decompensated liver disease – who, when and for how long?	4
An overview of the efficacy, safety, and predictors of achalasia treatments	4
Progressing advanced therapies for inflammatory bowel disease: Current status including dual biologic therapy and discontinuation of biologics	4
Electrosurgical unit in GI endoscopy: the proper settings for practice	4
Impact of GLP-1 receptor agonists on gastrointestinal function and symptoms	4
The value of endoscopic ultrasonography for differential diagnosis in obstructive jaundice of the distal common bile duct	4
Diagnosing and managing gastroparesis - where are we now?	4
Is oncolytic adenoviral-mediated immunotherapy through p53-overexpression the solution to refractory pancreatic ductal adenocarcinoma?	4
Therapeutic effect of ustekinumab on patients with extra-intestinal manifestations of Crohn’s disease	4
Diagnosis of peritoneal tuberculosis by real-time immuno-PCR assay based on detection of a cocktail ofMycobacterium tuberculosisCFP-10 and HspX proteins	4
Multiparametric intestinal ultrasound in inflammatory bowel diseases: a narrative review	3
Imaging in MASLD	3
Dupilumab is efficacious for eosinophilic esophagitis irrespective of prior swallowed budesonide or fluticasone, or prior treatments used alongside swallowed topical corticosteroids: results from the	3
Intermediate hepatocellular carcinoma: new horizons and prospects for our patients	3
Metabolic dysfunction-associated steatotic liver disease and gastrointestinal cancer risk in youth: is it time to unveil a hidden link?	3
Histologic assessments in ulcerative colitis: the evidence behind a new endpoint in clinical trials	3
The necessity and safety of simultaneous cholecystectomy during gastric surgery for patients with asymptomatic cholelithiasis	3
Gastric acid secretion therapy: long-term effects on gastric mucosa and polyp formation	3
Survival benefit of adjuvant transcatheter arterial chemoembolization for patients with hepatocellular carcinoma after anatomical hepatectomy	3
Same versus separate sessions of endoscopic ultrasound-guided fine-needle biopsy and endoscopic retrograde cholangiopancreatography for distal malignant biliary obstruction: a propensity score-matched	3
Guideline comparison for fatty liver disease: European (EASL-EASD-EASO) and Asian (APASL) perspectives	3
Cellular senescence and its pathogenic and therapeutic implications in autoimmune hepatitis	3
Pathophysiology and therapeutic management of anemia in gastrointestinal disorders	3
Could modulating the esophageal microbiome be the answer for eosinophilic esophagitis treatment?	3
Hemostatic powders and gels in gastrointestinal endoscopy: current perspective and future recommendations	3
Endoscopic ultrasound-guided radiofrequency ablation of pancreatic insulinoma: a state of the art review	3
Research progress on short-term prognosis of acute-on-chronic liver failure	3
Abdominal pain in children: guidelines at last	3
What can real-world data teach us about treating patients with unresectable hepatocellular carcinoma?	3
Risk factors for recurrent common bile duct stones: a systematic review and meta-analysis	3
A critical review of adalimumab for the treatment of moderate-to-severe active ulcerative colitis in children	3
Achalasia, from diagnosis to treatment	3
Response to letter: ‘Bayesian analysis and the role of local palliative therapeutics for malignant biliary obstruction’	3
Noninvasive identification of metabolic dysfunction–associated steatohepatitis (INFORM MASH): a retrospective cohort and disease modeling study	3
The clinical implications of trial endpoints in immunotherapy for hepatocellular carcinoma	3
A role for immune modulation in achieving functional cure for chronic hepatitis B among current changes in the landscape of new treatments	3
Targeting neutrophils in inflammatory bowel disease: revisiting the role of adsorptive granulocyte and monocyte apheresis	3
Gastrointestinal reported outcomes following one anastomosis gastric bypass based on a multicenter study	3
The role of microRNAs on the pathogenesis, diagnosis and management of portal hypertension in patients with chronic liver disease	3
Algorithms for early detection of silent liver fibrosis in the primary care setting – a scoping review	3
The role of videocapsule endoscopy in the diagnosis and follow-up of celiac disease: a scoping review	3
A critical review of technical progress, clinical heterogeneity, and implementation challenges of artificial intelligence in digestive endoscopy	3
Risk factors associated with failure of endoscopic combined treatment to prevent varices rebleeding in patients with liver cirrhosis	3
Serological testing for celiac disease in children	3
New progress with calcium-binding protein S100A16 in digestive system disease	3